ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001043.1|SGR_1 # 1 # 1191 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.749	BGC0001043.1|SGR_1 	1	1191	-	Loose	525	28.8758	LRA-1	29.51	3002482	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	TTGACCACGACCGACCCCACGCGTCCGGCCCCGGTGCCGATGCACCGGCTGTTCTTCGAGGAACCGGGGCCGCCCCGTCCCGCCGAGCTCCCGGGAGGCGACCCGGCCTGGCTGGTCAGCCGGTACGCGGACGTCCGCCAGGTGCTCTCGGACCCCCGGTTCGGCCGGGCGCGGCTGTACGCCCCCGAGGCGCCCGCCCTCTCCGGCGTACCCGACCTCGTGAACAACCCCGACCTGATGTTCAACCAGGACGGCTCCGACCACCTGCGGCTGCGCCGCACCCTGAGGCGCGCGTTCACCCCGCGGGCCGTCGCCCGCTGGCGGCCGTGGATCGCCGCGACGGTGGAGGGGATCCTCGACCGGCTGGAGTCCCGGCCGCAACCGGCCGACGTGGTGGCGGAGTTCGCCCTCCCGCTTCCGGTGGCGGTGATCAGCCGCCTCATGGGGCTCGACGAGTCCGTGTGGGACCGGATGCGGTACTGGAGCGAACACGCCTTCTCCGACGGCACCCACGAGCGCGAACAGGTCGCGGCGGCCCTCAAGGAGTTCAGCGCGTTCGGCGCGCACCTGCTCGCGGAGCGGCGCAGCACCCCGGGCGAGGACCTGGTCAGCGGGCTCGTCACGGCGGCCGACGAGGAAGGCGGCGTTCCCGAGGCGCAGTTGGTCAGCCTCGTGTGCGGGCTGGTCGTCGGCGGCCACGACAGCACGATGACCATGCTCGGCAACGCGCTGCTCTACCTGCTGGGCGAACGCCGCGAGACCTGGCCCCGCCTCGGCGCCGACGAGGAGGCCGCCGGGCTCCTCGTGGAGCGCCTCGTCCACCTCGTCCCGCTGGGCGACGACCGGGGCAGCACCCGCCACGCCGCCGAGGACGTCGAGGTCTCGGGCGTGAGGATCCCGGCGGGCGCGATCGTGATCGCCGACTGCGGCATGGCCAACCGCGACCCGGAGGTCTTCCCGCCCGCCACCCTGTACGACCTGTTCGCCCCGCTGGAGGCCCCGACGCTCTCCTTCGGCGCCGGCCCCCACTACTGCCTCGGCGCCTGGCTGGCCCGCACGGAGCTCCAGCTCGCCCTGCACCGCCTGGCCGCCCGCTTCCCGGAACTGCGCCTGGCCGACCCCGTCGACGCGGTCGTGTGGCGGACCGGGACGACCTCCCGCAGCCCGCGGCGGCTCGGCGTCAGGTGGTAG	MTTTDPTRPAPVPMHRLFFEEPGPPRPAELPGGDPAWLVSRYADVRQVLSDPRFGRARLYAPEAPALSGVPDLVNNPDLMFNQDGSDHLRLRRTLRRAFTPRAVARWRPWIAATVEGILDRLESRPQPADVVAEFALPLPVAVISRLMGLDESVWDRMRYWSEHAFSDGTHEREQVAAALKEFSAFGAHLLAERRSTPGEDLVSGLVTAADEEGGVPEAQLVSLVCGLVVGGHDSTMTMLGNALLYLLGERRETWPRLGADEEAAGLLVERLVHLVPLGDDRGSTRHAAEDVEVSGVRIPAGAIVIADCGMANRDPEVFPPATLYDLFAPLEAPTLSFGAGPHYCLGAWLARTELQLALHRLAARFPELRLADPVDAVVWRTGTTSRSPRRLGVRW	MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS	134.24	gnl|BL_ORD_ID|1464|hsp_num:0	1601			99	444	
BGC0001043.1|SGR_2 # 1240 # 2295 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0001043.1|SGR_2 	1240	2295	-	Loose	660	45.4394	MexS	26.27	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGATCGCGAAATGGGTGGTCCGCGAACACGTCGAAGGAGTCCCCGACGTGGACCGCGTCTACGAGAAGATCGTCGAGAACGTCGACGTGAGGCTCGCCCCCGACGAGATGCTCCTGCGCACCCTGTACGTCTCCGTCGACCCCTACCTCCAGGGCATCGCCCTCGACACCCCGATCGGCCGGCACATGGGCGCCGACTCGATCATGGAGGTGGTGGAGGCGGGACCGCGCGCCGCCCACCGCGTCGGCGACCTCGTCCAGGGCTTCGGGGGCTGGCGCACCCATGTGGTCTCCACCGGCGTCCCCGAACTCTGGCAGACCGGCACGTTCCCCATGGTCTTCCCCGCCTACCGCAGGCTGGACCCCCGGTGGTACGACGACGCCCTGCCGCTCCCGACCGCCCTCAGCGTGATGGGCGGCCCCGGCATGACGGCCTGGGGGACCCTGACCAAGTACATGACGATCAGCCCCGGCGAGACCCTCGTCATCAGCGGGGCCTCCGGGCCGGTGGGCGCCCTGGTCGGGCAGCTCGCCGCGCTCGCCGGGGCCCGGGTGATCGGCACCACCTCCTCCCCGGAGAAGGCGGACTACCTCACCGGGCTCGGGTTCGACGCCGTGATCGTCTACCGCCACGGGGACGGTGCGGACACCGTCGGCGACGCACTCGTCCGGGCCGCGCCCGACGGCGTCGACCGCTACTTCGACAACCTCGGCGGCGCGGTCACCGACGCCGTGTTCCCCCTGCTCAACATCGGGAGCCAGGTGGCGGTGTGCTGGCAGTGGGCGACCCAGGTCGGCAACGAGGCCACCGGTCCCCGGCTCCTGCCCTACCTGATGTTTCCCCGCGCCACCGTCCGCGGCATCTTCTCCCTGGAATGGTTCACCGAACAGAACTGGCAGGACCTCCACACCGAGCTGGGCGGCCGCGTCCGACGCGGCGAGGTCGTCTGCGACCACACCCTGCACCACGGCTTCGACGCGATCCCCGCCGCCTACGGCAGCCTCTACGGCGACCGGGCGGCCAACCGGGGCAAGGTACTCGTCGAACTCTGA	MKIAKWVVREHVEGVPDVDRVYEKIVENVDVRLAPDEMLLRTLYVSVDPYLQGIALDTPIGRHMGADSIMEVVEAGPRAAHRVGDLVQGFGGWRTHVVSTGVPELWQTGTFPMVFPAYRRLDPRWYDDALPLPTALSVMGGPGMTAWGTLTKYMTISPGETLVISGASGPVGALVGQLAALAGARVIGTTSSPEKADYLTGLGFDAVIVYRHGDGADTVGDALVRAAPDGVDRYFDNLGGAVTDAVFPLLNIGSQVAVCWQWATQVGNEATGPRLLPYLMFPRATVRGIFSLEWFTEQNWQDLHTELGGRVRRGEVVCDHTLHHGFDAIPAAYGSLYGDRAANRGKVLVEL	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	103.54	gnl|BL_ORD_ID|1039|hsp_num:0	1041			390	1011	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001043.1|SGR_3 # 2292 # 3959 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0001043.1|SGR_3 	2292	3959	-	Loose	600	29.6462	Streptomyces venezuelae rox	43.24	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGATCATCATCGGGGCCGGTCTCGGCGGGCTCTCCACCGGCTGCTACGCCCAGATGAACGGCTACCGCACCCGCATCCTGGAGATGCACGAGATCCCCGGCGGCTGCTGCACCGCCTGGGAGCGCGGCGGGTTCACCCTGGACGCCTGCGTCAGCTGGCTCCTGGGCAGCGGCCCCGGCAACGAGATGCACCAGATCTGGCTGGAGCTCGGCGCCCTCCAGGGCAAGGAAATCCGGCACTTCGACGTCTTCAACATCGTGCGCGGCACGGACGGCCGGGCCGTCCACTTCTACTCCGACCCCGACCGGCTCGAAGCCCACCTCATCGACATCTCACCCGCCGACGCCCGCCTCGTACGGAAGTTCTGCGCCCAGCTCCGCAGCTTCCGCAAGGCGCTGGCGGTCTACCCCTTCCTCAAGCCCGTCGGACTGATGGGACGCCGGGAGCGGTGGCGGATGCTCGCCTCGTTCCTGCCGTACTTCAACGCCGTCCGCACCACGATCACCGTCCTGATGAGCGACTTCTCCCAGAAGTTCAAGGACCCCCTCCTCCAGGAGGCGTTCAACTTCATCCTGTACGAGAAGCACCCGGCCTTCCCCGTCCTGCCCTTCCACTTCCAGCTCGCCTCGCACGCCAACCTCTCCGCCGGGGTCCCCGAGGGCGGCTCCCTCGGCCTCGCCGAGTCGATCGAGGCCCGCTACCGCCGGCTCGGCGGCGAGGTCTCCTACAACACCAAGGTCGAGACGGTGATCGTCGAGGACGACCGGGCGGTGGGCGTCCGCCTCAGCGACGGCCGGGAGATGCGCGCCGACATCGTCGTGTCGGCCTGCGACGGCTACACCACGACCATGAAGTTCCTGGAGGGCGAGTACCTGGGCGAGGACTACCGCAAGCTCTACACCGAGACCATCCACGAACCCGGCATGGTCTTCCCCGGCTACTTCACCCTCTTCCTCGGCCTCTCCCGCCCCTTCCCGGAGGGAGACCCCTGCACCACCCACCTCCTCGACGGGGCGACGGCCGCGGAGCTGACCGGCATCCGCCACCCCAGCATCAACGTCCAGTTCCGCAGCCGCCACTACCCCGAGCTTTCCCCGGACGGCACCACCGTCGTCTACGCCACCTACTTCTGCGACATCGCCCCCTGGCGAGCCCTGGACGAGGGCCCCGAACAGATCACCCGCACCCGCGGCGGCCAGGAGCTGCACACCCTGCCCGTACGCCACGGGCGCGGCTACTACGCCGCGAAACGGCGGGCCCGCGAGGCACTCATCGGCTTCCTGGAGGAGCGCCACCCCGGACTGCGGGACGCGATCGTCGTCCGGGACGTCTCCAGCCCCCTCACCCAGGTCCGCTACACCGGCAACTACGACGGGACCGTGCTGGGCTGGCAGCCCTTCGTCGAGAGCGGCGAGACCCTGGAGGAGCTGATCAAGAAGCACGGTCCGGGCCTCCCCGGACTGCGCGACTTCTACCAGTCGGGCGTCTGGGCCACCACCGGCGGACTCATCCGGGCCGCCGCCGCCGGACGCCACGTCATGCAGTTCGTCTGCCGCGACGACGGCAAGCCCTTCACCGCGTCGCTCGACCGCACCGCACCGCCACCGACCCACCGGGTCATCCCCGTGCCCGTTCGTCCCGCCGCACCGACGGAGAGGAAGTCATGA	MIIIGAGLGGLSTGCYAQMNGYRTRILEMHEIPGGCCTAWERGGFTLDACVSWLLGSGPGNEMHQIWLELGALQGKEIRHFDVFNIVRGTDGRAVHFYSDPDRLEAHLIDISPADARLVRKFCAQLRSFRKALAVYPFLKPVGLMGRRERWRMLASFLPYFNAVRTTITVLMSDFSQKFKDPLLQEAFNFILYEKHPAFPVLPFHFQLASHANLSAGVPEGGSLGLAESIEARYRRLGGEVSYNTKVETVIVEDDRAVGVRLSDGREMRADIVVSACDGYTTTMKFLEGEYLGEDYRKLYTETIHEPGMVFPGYFTLFLGLSRPFPEGDPCTTHLLDGATAAELTGIRHPSINVQFRSRHYPELSPDGTTVVYATYFCDIAPWRALDEGPEQITRTRGGQELHTLPVRHGRGYYAAKRRAREALIGFLEERHPGLRDAIVVRDVSSPLTQVRYTGNYDGTVLGWQPFVESGETLEELIKKHGPGLPGLRDFYQSGVWATTGGLIRAAAAGRHVMQFVCRDDGKPFTASLDRTAPPPTHRVIPVPVRPAAPTERKS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	116.60	gnl|BL_ORD_ID|4833|hsp_num:0	5820			378	486	rifampin; rifaximin; rifapentine
BGC0001043.1|SGR_4 # 4013 # 5695 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0001043.1|SGR_4 	4013	5695	-	Loose	600	30.4166	Streptomyces venezuelae rox	29.85	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCGGATGACGACCCCACCGACTGGACCAGCAGGGAACGCGCCCCGGGGACCCCGCCCCGCGTCATCGTCGTCGGCGCGGGCGTGGCCGGCCTCGCCACCGGTGTGTACGCGCAGATGAGCGGGGCCAGGACTCGCATCTTCGAGAAGCACGTGCTGCCCGGTGGCTGCTGCACCGCCTGGTCCCGCGACGGCTACCTCTTCGACTACTGCATCGAATGGCTCATCGGCACCGCCCCGGGCAACGACGCCCACCAGGTGTGGAGCGAGCTCGGCGCGTTCGACGGCAAGACCGTCACCAACTTCGAACTGTTCAACAAGGTCGAGGACGCCTCGGGCAGGTCGGTGACGTTCTACAACGACCCCGACCGGCTGGAGGCCCACCTCCTGGAGGTCTCACCCGCCGACGCCCCGCTCATCCGCGCCTTCACCCGGGACCTGCGGCGCTTCATCGACATCGAGCTGTACCCGTTCCTGACCGCGCCCGCGCTCCGGACCGTGGGGGAGCGGGCCCGGACCCTGCGCACGGTGCTCCCCGCCTTCCGGCTGTTCTGGCGGACCGCCGCCACCCCGATGCACGTGTTCGCCGACCGGTTCCAGGACCCGTTGCTGCGCAGGGCGTTCCGCAACATCTTCTTCCAGGACCCCGAGGGCTTCCCGATGCTGCCGTACCTCTTCAACATGGCGGCCGCCCACCACGGCAACGCGGGCTTCCCCCAGGGCGGTTCGCTCGGCCTCGCCCGCTCCGTCGAGGAGCGCTACAGGAGCCTGGGCGGAACGGTCACCTACCGGGCCCGCACCGAACGGATCCTGGTCGAGGACGACCGGGCGATCGGCATCGAACTCCGCAACGGCAAGCAGTACTTCGCCGAGCACGTGGTCTCCGCCTGCGACGGCCACACCACCGTCTACGGGCTCCTGGGCGGCCGGTACACCGGCCCCCGGATCGACAAGCTCTACACCGACCTGCTGCACCGCCCCGGCACCCTCTTCCCCGCCGTCGTCTCCGCCTTCGTCGGCCTGCGCGGCGACCTGGAACCCGAGGAGGCGCACAGCACCACGCACCTCCTCGGCCCGGAGGACGCGGCCCACCTCCCGGGCGCCCTCCAGGACAGCATCGTCGTGCAGGCACGCTCCCGCTACTCCGGCGGCTTCGCACCGCCGGGCCACTCCGTCCTGCACTGCACCTACTTCAGCGACTACGCCCACTGGAAGAACCTCCGCACCAGGGACCGCAAGGAGTACCGCCGGCGCAAGCGCGAAGTCGCCGACTTCGTCCGGGACTTCCTGGAGCGCCGCACCCCGGGCATCGCGGAGCGCATCGACATCGTCGAGGTCGCCACACCGGCCACGACCCACCGCTACACGGGCAACCTCGGCGGCTCCATCCTCGCCTGGAAGGCGTTCTCCGACGCCGACGACGTCGCGGCACGCCTCGTCGGCAAGGACCGGATGCGGCTGCCGGGACTGAGCAACTTCTCCATGGCCGGACAGTGGGTCGGCATGGGCGGCCTGATCCGCGCCGCCTCCACCGGCCGCTTCGCGGTCCAGTACCTCTGCCGCGACCTGGGCCTGGAGTTCCGGGCCTGGGAGAGCAAGGGCGCCGAACCCTGGCATCCGGGGAAGCTGGGGCACCTGCCCCAGCTCGACCGGTGGTCCGCACGGGAGAGCGAGGAAGCGTGA	MADDDPTDWTSRERAPGTPPRVIVVGAGVAGLATGVYAQMSGARTRIFEKHVLPGGCCTAWSRDGYLFDYCIEWLIGTAPGNDAHQVWSELGAFDGKTVTNFELFNKVEDASGRSVTFYNDPDRLEAHLLEVSPADAPLIRAFTRDLRRFIDIELYPFLTAPALRTVGERARTLRTVLPAFRLFWRTAATPMHVFADRFQDPLLRRAFRNIFFQDPEGFPMLPYLFNMAAAHHGNAGFPQGGSLGLARSVEERYRSLGGTVTYRARTERILVEDDRAIGIELRNGKQYFAEHVVSACDGHTTVYGLLGGRYTGPRIDKLYTDLLHRPGTLFPAVVSAFVGLRGDLEPEEAHSTTHLLGPEDAAHLPGALQDSIVVQARSRYSGGFAPPGHSVLHCTYFSDYAHWKNLRTRDRKEYRRRKREVADFVRDFLERRTPGIAERIDIVEVATPATTHRYTGNLGGSILAWKAFSDADDVAARLVGKDRMRLPGLSNFSMAGQWVGMGGLIRAASTGRFAVQYLCRDLGLEFRAWESKGAEPWHPGKLGHLPQLDRWSARESEEA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	117.65	gnl|BL_ORD_ID|4833|hsp_num:0	5820			336	537	rifampin; rifaximin; rifapentine
BGC0001043.1|SGR_5 # 5685 # 15155 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0001043.1|SGR_5 	5685	15155	-	Loose	1000	96.6709	almE	27.78	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCCGACGCGAACAACCGGGCGTTACGGAACAAGGTGGCGATCATCGGGATGGGCTGCCGCCTGCCCGGCGGCGCATCGGACCACCGCACCTACTGGCGCAATCTGGTGGAGGGCAAGGACTGCATCACGCCCACACCGCCCGACCGGTACGACGTCAGCACGCTCGGCAGCCGGTTCCGCGACAAACCCGGGCGTCTCGTCGGCGGACGCGGCGGATACATCGACGGGTTCGACGAGTTCGACCCCGCGTTCTTCGGTATCAGCCCCCGTGAGGCCGACCACATGGATCCCCAGCAGCGCAAGCTGCTCGAAGTGGCGTGGGAGGCCCTGGAGGACGGCGGTCAGCGGCCCGGGGACCTCGCCGGCGGCAACGTCGCCGTCTACGTCGGCGCGTTCACCCTGGACTACAAGATCCTGCAATTCGCCGACCTGGGCTTCACCTCGCTGGCCGCCCACACCGCGACCGGCACCATGATGACGATGGTGTCGAACCGCATCTCGTACTGCTTCGACTTCCGCGGCCCCAGCCTCTCCATCGACACCGCGTGCAGCTCCTCCCTGGTCGCCGTCCACCTGGCCTGCCAGGCACTGAACAACGGGGAGAGCGACCTCGCGCTGGCCGGCGGCACCCTGCTGCACATGGCCCCGCAGTACACCGTCGCGGAGACGAAGGGCGGGTTCCTGTCGCCCGAGGGGCGCTCCCGTACGTTCGACGCCGCCGCCGACGGCTACGTACGGGCCGAAGGCGTCGGCCTGGTGGCGCTCAAGCGACTGGACGACGCCGTACGGGACGGGGACCGGATCCACGCGGTGATCGCCGGCAGCGGCGTCAACCAGGACGGGCACACCAACGGCATCACCGTGCCCAACGCCGACGCCCAGGTCGACCTCATCCGCCGGGTCTGCGCGGAGGCGGGCATCACCCCCGGCGACCTCCAGTACATGGAGGCGCACGGCACCTCGACCCCGGTCGGCGACCCCATCGAGGCGAACGCCCTGGCACGCGCGCTCGCCGTCGGACGCGCCCCGGGCGCCCGCGCCTACGTCGGCTCGGTCAAGACCAACATCGGCCACACCGAATCCGCCGCCGGGATCGCCGGGCTGATCAAGACCGTCCTGAGCATCGAACACCGCACGATCCCGCCCCACATCAACCTGGAGAACCTCAATCCCGCCATCGACCCGGCGGCCCTCCCCTACGAGATCCCCACCCGGCCCACCCCCTGGCCCGAGCACGAAGGGCCCGCCCGCGCCGGGGTCAACTCCTTCGGCTTCGGCGGCACCAACGCCCACGTCGTCCTGGAGGAGGCCCCCGGGCCCCTGCCGGACACCCGCCCCGTCACGTCCGGAGCGTCCGCCGGCCGACGCTGGAGCATCCTGCCCCTCAGCGCCCGCAACCCCGACGCCCTGAAGGAGATGGCGGCCGGGATCCGGAGCGAACTGGCGGGCGCGAACGGCCCGGCCGTGACCCTCGACGACCTCGGCCACACCCTGGCCCACCGCCGCCAGCACCTTCCCGAGCGGCTGTCCGTCGCCTACACCTCGCGCGCCTCCCTCGACGAGGCCCTCGCCGCCCACGCGCGCGGCGACGCCCACCCCCGGGTCGTCCACGGCCGCGCCCGGGACGCCGCGGACCGGCGGCTGGTGTGGGTCTTCACCGGCATGGGTCCCCAGTGGTGGGGCATGGGCCGCCAACTCCTGGAGGAGGAACCGGTCTTCCGTGACGCCGTCGCCGCGTGCGACCGGGCGATGCGGGAGTTCGCCGACTGGTCCCTCATCGAGGAGATGACCGCCGACGAGCCGGTCTCCCGGATGGCGGAGACCTGGCTGGCCCAGCCCGCGAACTTCGCCGTACAGGTCGGCCTGGCGGCCCTCTGGCGGTCCCACGGGGTGCGTCCGGACGCCGTGGTCGGCCACAGCACCGGTGAGATCGCCGCCTTCCACGCGGCGGGCGTCTACTCCCTGCGGGACGCGGCCAGGGTCGTCGTGCACCGCAGCCGCCTCCAGCAGACCCTGGCGGGCACCGGCGCCATGCTCGCCGTCAGCCTCTCGGAGGACGAGGCCGAGCGCCGGGTGCGCCCCTACAGCGACCGGGTCTCCATCGCCGCCGTCAACAGCCCCACCGCGATCACCCTCGCCGGGGACGAGGCCGCGCTGACCCTGCTGGCCGAGGAGTTGCGGGCCGAGCAGCAGTTCGCGAAGTTCCTCACGGTCGAAGTGCCCTACCACAGCGTCGTCATGGAGCGGATCAAGGAGGAACTGCTCATCGAACTGGCACCGTTGGAACCGCGCACCGCCCAGGTCCCGCTCTACCTGACGGGTGCCGAGGGGACCGCCCGGGGCGAGGAACTGGACGCCGCCTACTGGTGGAAGAACGTCCGCGACCGGGTGCGCTTCCGCTCCGCCGTCGACCGCGTCGCCGCCGACGGCCACCGGGTGTTCCTGGAGATCGGCCCGCACCCCGTCCTCGGCCACTCCATCGGAGAATGCCTCGAAGCGGGCGGGACGAGCGGACTCACCCTGCCCTCGATCCGCCGCCGGGAGAACGAGGGCGAGCGCTTCGCCGCCTCCCTCGGCTCGCTCCACAACCTGGGCGTCGCCATCGACTGGAACGTCCTCCAGCCGGCCGGCCGGCCGGTCACCCTGCCCCGCCACCCCTTCCGGCGCGACCGGCACTGGACCGAACCCCGGCCGGTCGCACAGGTCCGGCTCGGCCACCGCGACCACCCCCTGCTGGGCCGCCGCACCGACCGTACGGAGCCCACCTGGCAGGCCCGCCTGGACACCGAGGACCTGCCGTACCTCGCCGACCACCGCATCCAGGACACCGTGGTCTTCCCCGCCGCCGGCTACCTGGAGATGGCCGCCCAGGCCGTCCTGCGGCTCACCGGCGGCACCACCGCCGTCCTCGCCGACATCGATCTGCGCAAGGCCCTCTTCCTGCCCGACGGCGAGGACCGGACCGTGGAGCTGTCGCTCTCCCTGGAGAACGCCGCCTTCACCATCGCGTCCCCGACCGGGGACGACGGCGAACGCGCCGTGCACGCGAGCGGGATCGTCCGCACCGGCCAACGCCGCCGCACCGCCCCGCCGCTGGACGCCCCCGCGCTCCGCGCCAGGTCCTCGCGGCACCTCCGAGGCCCCGACTGCTACACCGCGCTGGCCGCCCTCGGCTACCACTACGGCCCCGCCTTCCAGGCCATCGAGGAGGTCTGGATCGGCGCCGGGGAGGTCCTCGCCCGGATCCGCCCGCCCCGGGCGATCGGCGACGCCGCCGCCGGCCACCACCTCCACCCCGTCCTCCTCGACGCCTGCTTCCAGACGCTCCTGACCCCGCTGATCCCGCCGACCCCCGAGGACGCCGCCCCGGACACCGGGATCAGGCTGCCGCTCTCCCTGGACGAGGTCGCCCTCGAACCCATCGGCGACCAGCCGTTCTGGGCCCACGCCACCCTGCTCCCCGGCGACGCCGGCACCACCCTCGGCAACCTCGCCCTGTACGCCGACGACGGGGAGCCACTCGGCCGCGTCCTGGGCTTCCGCGCCGCCGACGTCGAGAAGGCGGCCACCGCCGTCGCCCGGACCACGATCGACTCCTGGCTCGCCGAACCCGTCTGGACCGACTGCCCGCCCTTGCCCGCCGGGGACACCGGCGCCGCGCCGGTGAACGCCGACGACCGCGACGTACGCGGCGAGCCGACGGGGAGCACCACCGGACCCCGGCCGGCGCCCGCGACAGCGGCCCGGGACCACGACTGGCTGGTCCTCGCCGACAACGGGGGCACCGCCGACGCCTTCGCCGCCCTGGCCGCCGCCCGGGGCGAACGCTGCCGGCTGGTGCGCCGGGGCGCGGCCTACACCGCGTCCGCCGACGGCGCCGCCTTCACCGTCGACCCCGCGTCCGACGCCGATCTGCGCCGGCTCCTCGCCGACCTGGACCGCGACGGGGGCCCCTTCCGAGGGGCCGTCCTGCACCTGTGGAACCTGGACGCGCCCGCCCTCGCCACGTGCGACCGGGCCTCCCTGACCGACCACACCGGCGCGGGAGCGTACTCACTGATCGCCCTCGCCCGGCTCCTCTCCGCCCGGGGTACCGGAGGCCGACTGCACATCGTCACCCGCGGCGCCCAACCCGCCCTGCCCGGCGAGGGGCCCGAACCCCTCGGCGCACCCGCCTGGGGCATCGGCCGCGTGCTGCGGCACCAGGAACTGACCGAACACCCCGGCAAACTCATCGACCTCGACCCCCGGCGGCAGCCGGGCCCCGACGGCGACCTGGCCGAGGCCGCGGCGCTCCTCGGCGAAGTCCTCAGCGACGACGAGGAGGAGATCGCCCTGCGCGACGGAGGCCGCCGCACCAGCCGCCTGCGCCCGGCGCGGGAGCTGACCCGCCCGCTGCCGCCCCGCCTGCGCGCCGACGGCAGCTATCTGGTCACCGGCGCGTTCGGCGCGCTCGGCCGACTGCTGTGCCGCACCCTCGTACGCCGGGGGGCCCGCCGGATCATCCTGGTCGGGCGCACCCCCGTCCCGGCCCGCGAGAAATGGGCCGGTACCGACCCCGCCACCGCCGAGGGCCGGGCCGTGGCCCTGCTCCGCGAACTGGAGGCGCTCGGCGCGCAGCCCGTCCTCGCGACCCTCGACATCACCGACGAGGACGCCCTGACCGGCTGGCTCGACGCCCACCGGCGCAGCGGGGCGCCACCCGTACGCGGGGTGTTCCACCTCGCGGGACAGGTCCGTGACACCCTCGTCGCCGATCTGGACCGGGCCGCCTTCGACGCCGTCCACGACCCCAAGACCGTCGGCGCGCACCTCCTGCACCGGCACCTGCGGGACGAACCCCTCGAACACTTCGTCCTCTTCGCCTCGATCGCCTCGCTGCTGACCACGGCGGGCCAGACCAACTACGCCGCGGGCAACGCCTTCCTCGACGCCCTCGCCCACCACCGCCGCGCCCGGCACCTGCCCGCGCTCAGCCTGGACTGGGGCCCCTGGGCCACCGGGATGATCGAGGAACTCGGCCTGGTCGACCACTACCTGCACAGCCGCGGCATGAGCTCCCTGTCCCCGGAGGCCGGCATGGCCGTCCTGGAACGCGTCCTCGGCCAGGACCACGCCCAACTGGTCGTCGCCACCGTCGTCGACTGGCCCGTCTTCCTCGCCTGGTACCCCTCCCCGCCGCCGCTGGTCGCCGAGCTCGCCGCGGCCGCCGCCCCGCCGGCCGACGCCGCCTCCGGCAACGGATTCCTCGACACCTTCCGCGCCGCCGACGAGGAGACCCGCCGCACCCTGGTCGGCGAGCGGTTCGCCGCGCTCTCGGCCACCGTGCTGCGCACCGGCACCGACCGCATCGACCCCGCCACCGGACTCGGTGAGCTCGGCCTCGACTCGCTCCTCGCCATGGAGCTCCGGGCCCGGATCCACGCCGAACTCGGCGTCGCCCTCCCCGTGGTGGCCCTGCTCAGCGGCACCCCGGCCGGGGAACTCGCCGCCCAGCTCCACGACGGCCTCACCGCCCTGGCCTCGACCGACACCCCCGACGGGGCCCCAGGGATGGTGGAGCTCCACCACGACGAGGGGCAGTACCCGCTGACGCAGAACCAGAAGGCGCTCTGGTTCCTCAAGCACCTCAACCCCGACGGATACGCGTACAACATCGGCGGGGCCGTCGAGGTGAACGTCACGCTCGAACCGGACCTGATGTTCGAGGCCGTCCGCCGGCTCATCGCCCGGCACCCCGCGCTCCGCACCAACTTCCTCCTGGTGGACGGGCAGGCAGTGCAGCGGGTCTCCGAGAACCCCGCCACGGACCTCGCCCTCTTCGACGTCCAGGGGGAGGACTGGGAATCCATCCACGCCACGATCGTCCAGGAGTACCGCAAACCCTACGACCTCGCCCGGGACCCCCTGGTCCGCTTCCGACTCTTCAAGCGGGGCCCGGACCGCTGGATCATCATGAAGGCCGTCCACCACATCGTCTCCGACGCCATCTCCACCTTCACCTTCATCGAGGAACTCCTCGCCGTCTACGAGGCGTTGCGCCGCAACCAGGAACACCGGCTCCCCCCGGTCGAGGCCCGCTACCTCGACTTCCTCAACCAGCAGAACGCCTTCCTCGCCGGACCCGCGGCGGCGGGCATGCTCGACTACTGGCGCTCCCACCTGCCGGCCGAGGTGCCGCTCCTGGACCTGCCCGTGGACAAACCGCGCCCGGCGGTTCAGACCCACAACGGGGCCTCCGAGTTCTTCGTCCTGGACGACGCCCTCAGCGCCCGGGTCCACGCCCTGGCCCGCGCCCACGGCGTCACGCCGTTCATGGTGCTGCTCAGCGCGTACTACCTCCTGCTGCACCGCTACTCCGGACAGGACCACATCGTCGTCGGCAGCCCGGTCACCGGCCGCACCCGGCAGGACTTCTCCTCCGTCTACGGCTACTTCGTCAACCCGCTGCCCCTGCACGCCGACCTGTCCGAGGACCCGACCGTCGCCGAACTGCTCCAACAGGTCCGCCGGACCGTGCTCGGCGGCCTGGACAACCAGGAGTACCCCTTCGTCCTGCTCGTCGAGGAGCTGGGCCTCCAGCACGACCCCAGCCGCTCCGCCGTCTTCCAGGCCATGTTCATCCTCCTCACCCACAAGGTGGCCACCGAACAGTACGGCTACCGCCTGGAGTACATCGAACTACCGGAGGAGGAAGGGCAGTTCGACATAACACTGTCCGCCTACGAGGACGAGGCCGAGGGCCGCTTCCACTGCGTGTTCAAGTACAACACCGACCTCTTCCTCCCCGAGACCATGCGCCGCATGGCCGCCCACTACACCCGGCTCCTCGACCGGATGACCCGGGTGCCGGGCGAGCAGCCCTCCTCACGGCTGGAGATGCTCGGCGAGAGGGAGCGCGAACGGCTCGTCGAGGAGTGGAGCCGACCGGCCCTGCCGCCCGCCGGGCCCGGTGAGGAGCCGTTCACCCCGGTCCAGACGCTGATCGGCCGCGTCGCCGCCGAACACCCCGCGGCCGTCGCCGTCACCCTGCCCACCGCGCACGGAGAGGCGCGCCGGCTGACCTACGCCGAACTGGACCGGCGGGCCACCGGCACCGCCGCCCGGCTGCGGGCCCTCGGCATCGGCGAGGGCTCGGTGGTCGTCCTGTGCCTCGACAAGTCGCCCGAGCTGATCGCCGCCCTGCTCGGCGTGCTCAGGGCGGGCGCCGCCTACCTCCCGCTCCGGCCCGACCAGCCCGCCGACCGGCTCGCCCACCTCGTGACGGCCACCGGCGCGGCACTCGTCCTCGTCGCGGACGACGCCGCACCGGAGCAGACCGGAGCCCTGACCGTCCCGACGCTCGGCCTCGCCGCGCTCGAACGCACCGAACCGCACCCGGAAGGACCGGCCGCCGCGCCCGGCCCCGACTCGCCCGCGTACGTCATCACCACCTCCGGATCCACCGGCCGCCCCAAGGCCGTCCGCGTCAGCCACCGCAACCTCGCCTCCGCCCACGCCGCGTGGCGCCAGGAGTACCGGCTGGACACCGACGTCCGCACCCACCTCCAGATGGCCGAACCGTCCTTCGACGTGTTCACCGGCGACCTGGTGCGCGCCCTGTGCTCGGGCGGCACCCTCGTCCTGGCCGACCGCGACCTCCTCTTCGACACCACCCGGCTCTATCGCACGATGCGTCAGGAACGCGTCGACTGCGCCGAGTTCGTCCCCGCCGTCGTCCGCGGCCTGATGGACCACTGCACGCGGGAAGGGCTGCGGCTGGACTTCCTGCGGCTGCTGGTGGTCGGCTCGGACGCCTGGAGCGTGGGGGAGTACCGCCGGCTGGCCGAGCTCTGCGGACCCGGCACCCGCCTGGTCAACTCCTACGGCCTCACCGAGGCCACCATCGACAGCGCGTTCTTCGAGGGGCCCGTCGACGACCTGGAGGCCGGCGCGATGGTCCCCATCGGCCGGCCCCTGCCCAACAGCACCCTCCACGTCCTCGACGCCCACGGCGAACCCGTCCCGCCCGGCGTGCCCGGCGAACTCTGGATCGGCGGCGACGGCGTCGCCCTCGGATACGCCGGAGACCCCGAGCAGACCGAGGAGCGCTTCGTCACCCGGGCGCTCGGCCGGGGAGTCGGCGCCCGGCCCGAACGGCTGTACCGCACCGGCGACATCGCCCGCTGGGACGCACAGGGCCGGGTCCACCTGCTCGGCCGCACCGACGGACAGGTCAAACTGCGCGGCCACCGCATCGAGATCGGCGAGATCGAGGCGCAGCTCGCCCAGTGGCCCCCGCTCGCCCGGGCCGTCGTCACCGTACGCACCGACACCGGGGGAGACGCGGCGCTCTGCGCCTACTGCGTCCCCGAGCCCGGCGCGGCCCTGGACGTCCGGGCCCTGCGCCGCCACCTGGCGCGCTCACTGCCCTCGTACATGATCCCTTCGCACTTCACCGAGCTGCCCGCCCTGCCGCTGACGGCCAACGGCAAGGTCGACACGGCCGCCCTGCCCGCCCCGCGGGCGGAGGCCGGGGACCGGCCGCACGAGGAGCCCGTGACGCTGTACGAGATCAGCGTCGCCCGCCACTGGAAGACCCTCCTGGGACGCGAACACGTCGGCCTGGAGGACGACTTCTTCGAACTCGGCGGCAGCTCCATCAAGCTCATCGAACTCCTCCACCACCTGCGCACCGAGTTCGGCGTGGGCGTGCCCGTCAGCAGGCTCTACCAGGTCACCACGTTGCACGGGATGGCCGCCACCGTGGAGGACGTCCTGCTCGGCACCACCGCCGACGAACTGCCCCGCCTCACCTTCAACGCCGGACAGGCCCCCGCCCTCTTCTGCTTCCCGCCCGCGGGCGGCCACGGGCTCGTCTACCGCGGGCTGGCCGCCCAGCTCCCCGACTACTCCGTCACCGGCTTCAACTACCTCCCCGGCGACGACAAGGTCAGCCGGTACGCCGACCTGATCGAGGCGGACCGGCCCGACGGCCCCTACCTGCTCCTGGGCTACTCCCTCGGCGGCAACCTCGCCTTCGAGACGGCCAAGGAGCTGGAGCGGCGCGGCCGGGACGTCGCCCACGTCGTCATCCTCGACTCCCGCCGCATCCTCGCCGCGTACGAGCCGGACGCCTCGGGCATCGCCGCCTTCGAGAGCGAACTCGCCGACCACGTACGCAAGCACACCGGCTCCGAGGCCGTCGCCCACGAGACGCTCGCCCACGCGGCCGAATACCTCGCCTTCTGCGGGCGCACCCCCAACACGGGCACGGTCGCCGCGACCGTCAGCGTGATCACCGACGAGGAGAAGACCGCCCTCTACGCCGCCGGGGAGCACGGCACCTGGCACGGCAGCTCCACCGGAGCCACCGCCGTACTGCGCGGCTCCGGTGTCCACGCCGACATGCTCGACGCCAAGCACCTGCCCCGCAACGCGGAGCTGGTGCGCTCCGTCCTGGGGGGAGACGCGGCCCATGGCGGATGA	MADANNRALRNKVAIIGMGCRLPGGASDHRTYWRNLVEGKDCITPTPPDRYDVSTLGSRFRDKPGRLVGGRGGYIDGFDEFDPAFFGISPREADHMDPQQRKLLEVAWEALEDGGQRPGDLAGGNVAVYVGAFTLDYKILQFADLGFTSLAAHTATGTMMTMVSNRISYCFDFRGPSLSIDTACSSSLVAVHLACQALNNGESDLALAGGTLLHMAPQYTVAETKGGFLSPEGRSRTFDAAADGYVRAEGVGLVALKRLDDAVRDGDRIHAVIAGSGVNQDGHTNGITVPNADAQVDLIRRVCAEAGITPGDLQYMEAHGTSTPVGDPIEANALARALAVGRAPGARAYVGSVKTNIGHTESAAGIAGLIKTVLSIEHRTIPPHINLENLNPAIDPAALPYEIPTRPTPWPEHEGPARAGVNSFGFGGTNAHVVLEEAPGPLPDTRPVTSGASAGRRWSILPLSARNPDALKEMAAGIRSELAGANGPAVTLDDLGHTLAHRRQHLPERLSVAYTSRASLDEALAAHARGDAHPRVVHGRARDAADRRLVWVFTGMGPQWWGMGRQLLEEEPVFRDAVAACDRAMREFADWSLIEEMTADEPVSRMAETWLAQPANFAVQVGLAALWRSHGVRPDAVVGHSTGEIAAFHAAGVYSLRDAARVVVHRSRLQQTLAGTGAMLAVSLSEDEAERRVRPYSDRVSIAAVNSPTAITLAGDEAALTLLAEELRAEQQFAKFLTVEVPYHSVVMERIKEELLIELAPLEPRTAQVPLYLTGAEGTARGEELDAAYWWKNVRDRVRFRSAVDRVAADGHRVFLEIGPHPVLGHSIGECLEAGGTSGLTLPSIRRRENEGERFAASLGSLHNLGVAIDWNVLQPAGRPVTLPRHPFRRDRHWTEPRPVAQVRLGHRDHPLLGRRTDRTEPTWQARLDTEDLPYLADHRIQDTVVFPAAGYLEMAAQAVLRLTGGTTAVLADIDLRKALFLPDGEDRTVELSLSLENAAFTIASPTGDDGERAVHASGIVRTGQRRRTAPPLDAPALRARSSRHLRGPDCYTALAALGYHYGPAFQAIEEVWIGAGEVLARIRPPRAIGDAAAGHHLHPVLLDACFQTLLTPLIPPTPEDAAPDTGIRLPLSLDEVALEPIGDQPFWAHATLLPGDAGTTLGNLALYADDGEPLGRVLGFRAADVEKAATAVARTTIDSWLAEPVWTDCPPLPAGDTGAAPVNADDRDVRGEPTGSTTGPRPAPATAARDHDWLVLADNGGTADAFAALAAARGERCRLVRRGAAYTASADGAAFTVDPASDADLRRLLADLDRDGGPFRGAVLHLWNLDAPALATCDRASLTDHTGAGAYSLIALARLLSARGTGGRLHIVTRGAQPALPGEGPEPLGAPAWGIGRVLRHQELTEHPGKLIDLDPRRQPGPDGDLAEAAALLGEVLSDDEEEIALRDGGRRTSRLRPARELTRPLPPRLRADGSYLVTGAFGALGRLLCRTLVRRGARRIILVGRTPVPAREKWAGTDPATAEGRAVALLRELEALGAQPVLATLDITDEDALTGWLDAHRRSGAPPVRGVFHLAGQVRDTLVADLDRAAFDAVHDPKTVGAHLLHRHLRDEPLEHFVLFASIASLLTTAGQTNYAAGNAFLDALAHHRRARHLPALSLDWGPWATGMIEELGLVDHYLHSRGMSSLSPEAGMAVLERVLGQDHAQLVVATVVDWPVFLAWYPSPPPLVAELAAAAAPPADAASGNGFLDTFRAADEETRRTLVGERFAALSATVLRTGTDRIDPATGLGELGLDSLLAMELRARIHAELGVALPVVALLSGTPAGELAAQLHDGLTALASTDTPDGAPGMVELHHDEGQYPLTQNQKALWFLKHLNPDGYAYNIGGAVEVNVTLEPDLMFEAVRRLIARHPALRTNFLLVDGQAVQRVSENPATDLALFDVQGEDWESIHATIVQEYRKPYDLARDPLVRFRLFKRGPDRWIIMKAVHHIVSDAISTFTFIEELLAVYEALRRNQEHRLPPVEARYLDFLNQQNAFLAGPAAAGMLDYWRSHLPAEVPLLDLPVDKPRPAVQTHNGASEFFVLDDALSARVHALARAHGVTPFMVLLSAYYLLLHRYSGQDHIVVGSPVTGRTRQDFSSVYGYFVNPLPLHADLSEDPTVAELLQQVRRTVLGGLDNQEYPFVLLVEELGLQHDPSRSAVFQAMFILLTHKVATEQYGYRLEYIELPEEEGQFDITLSAYEDEAEGRFHCVFKYNTDLFLPETMRRMAAHYTRLLDRMTRVPGEQPSSRLEMLGERERERLVEEWSRPALPPAGPGEEPFTPVQTLIGRVAAEHPAAVAVTLPTAHGEARRLTYAELDRRATGTAARLRALGIGEGSVVVLCLDKSPELIAALLGVLRAGAAYLPLRPDQPADRLAHLVTATGAALVLVADDAAPEQTGALTVPTLGLAALERTEPHPEGPAAAPGPDSPAYVITTSGSTGRPKAVRVSHRNLASAHAAWRQEYRLDTDVRTHLQMAEPSFDVFTGDLVRALCSGGTLVLADRDLLFDTTRLYRTMRQERVDCAEFVPAVVRGLMDHCTREGLRLDFLRLLVVGSDAWSVGEYRRLAELCGPGTRLVNSYGLTEATIDSAFFEGPVDDLEAGAMVPIGRPLPNSTLHVLDAHGEPVPPGVPGELWIGGDGVALGYAGDPEQTEERFVTRALGRGVGARPERLYRTGDIARWDAQGRVHLLGRTDGQVKLRGHRIEIGEIEAQLAQWPPLARAVVTVRTDTGGDAALCAYCVPEPGAALDVRALRRHLARSLPSYMIPSHFTELPALPLTANGKVDTAALPAPRAEAGDRPHEEPVTLYEISVARHWKTLLGREHVGLEDDFFELGGSSIKLIELLHHLRTEFGVGVPVSRLYQVTTLHGMAATVEDVLLGTTADELPRLTFNAGQAPALFCFPPAGGHGLVYRGLAAQLPDYSVTGFNYLPGDDKVSRYADLIEADRPDGPYLLLGYSLGGNLAFETAKELERRGRDVAHVVILDSRRILAAYEPDASGIAAFESELADHVRKHTGSEAVAHETLAHAAEYLAFCGRTPNTGTVAATVSVITDEEKTALYAAGEHGTWHGSSTGATAVLRGSGVHADMLDAKHLPRNAELVRSVLGGDAAHGG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	567.63	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
